Press Releases from U.S. HER2-Negative Breast Cancer Market (1 total)
U.S. HER2-Negative Breast Cancer Market Reports Steady Growth Despite Premium Pr …
The 210-page report titled “HER2-Negative Breast Cancer - US Drug Forecast and Market Analysis To 2023” discusses the unmet needs in the HER2-negative breast cancer market in the U.S., the current landscape of treatment options, the commercial opportunities present, and the existing pipeline.
Breast cancer is known to be the most common cancer among women and the second most common type in the world. Although the five-year survival rate in breast…
